Neha Mehta-Shah, MD, MSCI

Neha Mehta-Shah, MD, MSCI

Associate Professor

Address:
Division of Oncology
Mail Stop 8056-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110

11th Floor Mid Campus Center (office)

Admin:
Tonya Doublin
tonya@wustl.edu

Clinical Interests
  • Non-Hodgkin lymphoma
  • Hodgkin lymphoma
  • T/NK-cell lymphomas
  • Cutaneous lymphoma
Research

I am interested in clinical and translational efforts to improve the care of patients with lymphoma. To date, my research has been focused on prospective and retrospective studies to better understand the biology of and to improve therapy for patients with peripheral and cutaneous T-cell lymphomas. In particular, I am interested in developing non-chemotherapeutic strategies for the treatment of these disorders. Additionally, I have a deep interest in evaluating the role of stem cell transplant in T-cell lymphomas and improved strategies for disease monitoring in this population.

Profiles (publications)
WU Physician Bio

Biosketch

Education

  • 2019-2016: Masters of Science in Clinical Investigation, Washington University in St. Louis, St. Louis, MO
  • 2009-2005: MD, Feinberg School of Medicine, Northwestern University, Chicago, IL
  • 2005-2002: BA, Psychology (Cum Laude), Northwestern University, Evanston, IL

Post-Graduate Training

  • 2019-2016: Masters of Science in Clinical Investigation (MSCI), Washington University, St. Louis, St. Louis, MO
  • 2016-2013: Fellow, Hematology/Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
  • 2015-2014: K30 Advanced Certificate in Clinical and Translational Investigation, Weill Cornell Medical College, New York, NY
  • 2015-2014: Chief Fellow, Hematology/Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
  • 2013-2012: Chief Medical Resident, Memorial Sloan Kettering Cancer Center, New York, NY
  • 2012-2009: Resident, Internal Medicine, New York Presbyterian-Weill Cornell Medical Center, New York, NY

Academic Positions & Employment

  • present-2022: Associate Professor of Medicine, Division of Oncology, Washington University Medical School, St. Louis, MO
  • 2022-2016: Assistant Professor of Medicine, Division of Oncology, Washington University Medical School, St. Louis, MO

Board Certification

  • 2016: Board Certified in Hematology
  • 2016: Board Certified in Oncology
  • 2013: Board Certified in Internal Medicine

Honors & Awards

  • 2023-2021: Alliance Scholar Award
  • 2022-2019: Lymphoma Research Foundation, Career Development Award
  • 2021-2019: T-cell Leukemia/Lymphoma Society Young Investigator Award
  • 2021-2019: T-cell Leukemia/Lymphoma Foundation Award
  • 2019-2018: McDonnell Genome Institute, Pilot Award
  • 2019-2017: Lymphoma Research Foundation Lymphoma Clinical Research Mentorship Program
  • 2019-2016: Paul Calabresi K12 Career Development Award
  • 2019: Top 10% Patient Satisfaction Scores, WUSM Department of Medicine
  • 2018: Clinical Research Training Center Outstanding Citizenship Award
  • 2015: Conquer Cancer Foundation Travel Award
  • 2015: ASCO/AACR Workshop on Methods in Clinical Cancer Research
  • 2015: American Society of Hematology Research Training Award for Fellows
  • 2015: Lacher Award, Memorial Sloan Kettering Cancer Center
  • 2013: Memorial Sloan Kettering Housestaff Teaching Award
  • 2012: David E. Rodgers Research Award, Weill Cornell Medical College
  • 2012: Richard Bowman Award, Weill Cornell Medical College
  • 2008: Recognition of Exemplary Physicianship, Northwestern University
  • 2008: Alpha Omega Alpha, Northwestern University

Editorial Responsibilities

  • present-2021: Editorial Board, Haematologica
  • present-2018: Editorial Board, Clinical Lymphoma, Myeloma and Leukemia
  • 2021: Lymphoma Research Foundation, Editorial Committee

National Scientific Panels

  • present-2017: National Comprehensive Cancer Network: Peripheral T-cell Lymphoma and Primary Cutaneous Lymphomas, writing member

Professional Societies & Organizations

  • present-2018: Member, Washington University Institute of Clinical and Translational Sciences
  • present-2018: Member, Cancer Support Grant for Siteman Cancer Center
  • present-2017: American Society of Hematology
  • present-2017: American Society of Clinical Oncology
  • present-2017: American Association for Cancer Research

Community Service/Committees

  • present-2022: Siteman Cancer Emerging Leaders Council
  • present-2021: ASCO Scientific Program Committee: Hematologic Malignancies-Lymphoma and CLL Track
  • present-2021: Siteman Cancer Center: Leukemia/Lymphoma Strategic Planning Workgroup (Member)
  • present-2021: Clinical Research Training Center Mentor Liaison Program
  • present-2021: Lymphoma Research Foundation Clinical Research Mentorship Program Faculty
  • present-2021: FDA Orphan Products Hematology/Oncology Study Section
  • present-2021: Data Safety Monitoring Board, Siteman Cancer Center/Hematology-Oncology Division
  • present-2020: Washington University Internal Medicine Residency Program Core Faculty Member, Program Evaluation Committee
  • present-2019: Washington University School of Medicine Admissions Committee
  • present-2019: Washington University School of Medicine Fellowship Core Competency Committee
  • present-2017: Washington University School of Medicine Fellowship Core Faculty Member, Recruitment Leader
  • present-2016: CALGB/Alliance Lymphoma Subcommittee

Board Memberships

  • present-2021: Annual International Ultmann Chicago Lymphoma Symposium, Steering Committee
  • present-2020: American Society of Hematology, ASH GENOM Steering Committee